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Abstract
In the United States, diabetes is common and costly. Programs to prevent new cases of diabetes 
are often carried out at the level of the county, a unit of local government. Thus, efficient targeting 
of such programs requires county-level estimates of diabetes incidence–the fraction of the non-
diabetic population who received their diagnosis of diabetes during the past 12 months. 
Previously, only estimates of prevalence–the overall fraction of population who have the disease–
have been available at the county level. Counties with high prevalence might or might not be the 
same as counties with high incidence, due to spatial variation in mortality and relocation of 
persons with incident diabetes to another county. Existing methods cannot be used to estimate 
county-level diabetes incidence, because the fraction of the population who receive a diabetes 
diagnosis in any year is too small. Here, we extend previously developed methods of Bayesian 
small-area estimation of prevalence, using diffuse priors, to estimate diabetes incidence for all 
U.S. counties based on data from a survey designed to yield state-level estimates. We found high 
incidence in the southeastern United States, the Appalachian region, and in scattered counties 
throughout the western U.S. Our methods might be applicable in other circumstances in which all 
cases of a rare condition also must be cases of a more common condition (in this analysis, “newly 
diagnosed cases of diabetes” and “cases of diabetes”). If appropriate data are available, our 
methods can be used to estimate proportion of the population with the rare condition at greater 
geographic specificity than the data source was designed to provide.
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In the United States, diabetes has an enormous social cost (American Diabetes Association, 
2008). Persons with diabetes are at increased risk of devastating complications that include 
blindness (Kertes and Johnson, 2007), hearing loss (Kakarlapudi et al., 2003), and kidney 
failure (Centers for Disease Control, 2011), and a person with diabetes is at about twice the 
risk of death as a person of similar age without diabetes (Centers for Disease Control, 2011). 
Having diabetes approximately doubles one’s medical costs (Centers for Disease Control, 
2011).
Diabetes is common, and becoming more so. In 2010, the national incidence (fraction of the 
population diagnosed in the preceding twelve months) was 8.6 per 1000 person years and 
the national prevalence (fraction of population who have the condition) of diagnosed 
diabetes was 6.0% (Centers for Disease Control and Prevention, 2012a). By 2050, the 
national diabetes incidence is projected to be 15 per 1000 and the national prevalence is 
projected to be at least 14.8% (Boyle et al., 2010). A child born in 2000 in the United States 
has a more than 1 in 3 risk of developing diabetes sometime in his or her life (Narayan et al., 
2003).
Programs to prevent new cases of diabetes and to prevent complications and diabetes 
mortality are generally conducted locally, often at the level of the county (a unit of local 
government in the United States) or county equivalent (hereafter “county”). State-level 
estimates of the prevalence of diagnosed diabetes have long existed, based on data from the 
Behavioral Risk Factor Surveillance System (BRFSS), an ongoing, state-based, random-
digit-dialed telephone survey of non- institutionalized adults aged > 18 years in all 50 states, 
the District of Columbia, and some territories (Centers for Disease Control and Prevention, 
2012b). County-level prevalence estimates, pinpointing the counties with the greatest need 
for programs to prevent complications and death among persons with diabetes, have recently 
been developed, using model-based small area estimation techniques (Cadwell et al., 2010, 
Congdon and Lloyd, 2010, Srebotnjak, Mokdad and Murray, 2010).
Diabetes incidence and prevalence are obviously related; a person who develops diabetes, 
with rare exceptions, has the condition for life. However, incidence might or might not be 
high in areas of high prevalence, with differences stemming from spatial variability in 
mortality among persons with diabetes (a county with high incidence could have low 
prevalence, if mortality among persons with diabetes was large) and in mobility; for 
example, if incident cases in county A relocate to county B, they influence the incidence rate 
in A but not B, and the prevalence rate in B but not A.
To effectively target programs to prevent diabetes, we must identify areas of high incidence. 
However, historically, only state-level estimates of diabetes incidence have been available, 
and only for states that opted to conduct more in-depth interviews of persons with diabetes 
to determine when they were diagnosed.
Here, expanding on the work of Cadwell et al. (2010), in which BRFSS data were used to 
estimate county-level prevalence, we provide the first estimates of diabetes incidence for all 
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3,143 U.S. counties. Our underlying method is based on noticing that all incident cases of 
diabetes must also be prevalent cases. We first estimate county-level prevalence. We then 
estimate the county-level proportion of prevalent cases that are incident cases. Multiplying 
these together yields an estimate of incidence.
2. Methods
2.1 Data Sources
We use BRFSS data to model diabetes incidence. The BRFSS is a collection of cross-
sectional random-digit-dialing telephone surveys, conducted in all U.S. states and the 
District of Columbia. Every year, states conduct monthly telephone surveillance using a 
standardized questionnaire to determine the distribution of risk behaviors and health 
practices among noninstitutionalized adults. We use U.S. Census data to post-stratify the 
modeled estimates to be representative of U.S. counties in 2009.
County of residence for BRFSS respondents, while not included in the all versions of the 
data, was obtained for this study. For respondents with missing county of residence, we used 
the county most likely associated with the respondent’s telephone number. To make 
inferences from the sample to the population, post-stratification weights were attached to 
estimates. This use of post-stratification weights guarantees that our estimates are consistent 
with U.S. Census estimates of county population size.
For respondents indicating that they had diagnosed diabetes, an optional diabetes module 
was administered in some states in some years. On average, 41 states administered the 
diabetes module during 2008 through 2010, the years of data we used (combining three 
years of data follows the precedent set by Cadwell et al., and this approach was chosen 
because using fewer years resulted in some unstable estimates, due to smaller sample size). 
This results in some states having one year of data, some two years, and some three. One 
state had no diabetes module data.
The U.S. Census Bureau publishes population estimates by demographic characteristics 
(unit-level auxiliary information) for all counties (U.S. Census, 2012); the Census provides 
no information on diabetes status. We used the 2009 U.S. Census county projections to 
obtain estimates for the number of persons in each of the classes into which we group 
BRFSS data.
2.2 Diabetes Information Gathered
All BRFSS respondents were asked, “Have you ever been told by a doctor that you have 
diabetes?” Those who responded “no” were considered to not have diagnosed diabetes. 
Males who responded “yes” were considered to have diabetes. Females who responded 
“yes” were asked if they were told only during pregnancy. Those who indicated this had 
happened were considered have had gestational diabetes, which resolves at delivery, and 
were not considered to have diabetes. Females who had been told at any other time were 
considered to have diabetes. Respondents who did not know or refused to answer the 
question were considered to have missing diabetes status.
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Those who indicated that they had diagnosed diabetes and resided in states that administered 
the optional diabetes module were asked, “How old were you when you were told you have 
diabetes?” Age at the time of the survey and age at diagnosis, both self-reported, are 
measured in years and used to estimate the number of incident cases (2012a). If the 
difference between a respondent’s age and age at diagnosis is two or more years, the person 
is not considered an incident case. If the difference is zero years, the person is considered an 
incident case. If the difference is one year, the person is weighted as half an incident case; 
this method has been used previously to estimate diabetes incidence (Centers for Disease 
Control and Prevention, 2012a).
2.3 Incidence Modeling with Missing Data
The general framework for our model-based approach includes multilevel modeling 
followed by post-stratification (Gelman and Hill 2007, Chapter 14). Because of missing 
data, we use an approach analogous to “factoring the likelihood” (Little and Rubin 2002, 
Chapter 7). We specify a full Bayesian probability model that allows the posterior 
distribution to be factored into two parts that are estimated separately. Unlike the perhaps 
more familiar complete case analysis, this methods uses all the information on diabetes in 
the responses for which diabetes incidence status is missing.
Let Z1 = 1 if an individual was diagnosed with diabetes within the past year; Z1 = 0 
otherwise. Let Z2 = 1 if an individual was diagnosed with diabetes; Z2 = 0 otherwise. Since 
the distribution of prevalence given incidence, p(Z2|Z1), equals one, the distribution of 
incidence, p(Z1), can be written as p(Z1, Z2) = p(Z1|Z2)p(Z2). We develop separate models 
for incidence conditioned on the person being a prevalent case, p(Z1|Z2), and for prevalence, 
p(Z2). The estimates from the two models are combined to obtain an estimate of incidence, 
p(Z1). Assuming the parameters in the conditional incidence model and the prevalence 
model are distinct allows the distribution of incidence to be split into these two parts. See 
Appendix 1 for details.
For each of the 3,143 U.S. counties, sampled persons were cross-classified by age group 
(20–44, 45–64, 65+ years), sex (male, female) and race/ethnicity (non-Hispanic white, 
other); sample sizes did not support a finer division of race/ethnicity. This results in 12 
classes per county. The number of people sampled in each class who have diabetes can be 
determined. Specifically, let nij = the number of sampled people in county i, class j = 1, ⋯, 
12, and yij= the number of sampled people with diagnosed diabetes in county i, class j. In 
some years, in some counties, nij = 0. For each of these, the corresponding yij = 0. Let yij* = 
the number of sampled people with diagnosed diabetes in county i, class j = 1, ⋯, 12, whose 
incident status is known and rij = the number of sampled people with incident diabetes in 
county i, class j.
2.4 Prevalence Model
We fit a Bayesian multilevel model to the three years of BRFSS data, using methods similar 
to Cadwell et al., 2010, but differing in several ways (e.g., we used a Binomial distribution 
with a logit link instead of the Poisson distribution and logarithmic link that Cadwell et al. 
used). Our model and Cadwell et al.’s model yield similar, but not identical, estimates. Our 
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changes reduce the number of approximations (e.g., Cadwell et al. used the Poisson 
distribution to approximate the Binomial, while we used the Binomial).
Our model relates observed quantities to the twelve classes. In particular,
(2.1)
where pij = the prevalence of diagnosed diabetes in county i, class j. Let s(i) denote the state 
s that contains county i. The regression model includes:
a. logit link function log(pij/(1 − pij)).
b. fixed effect intercept for each class (age by sex by race/ethnicity group) 
.
c. random effects by county and class .
d. random effects by state and class .
e. spatial effects by state and class .
Parameters under (c) and (d) are modeled via 12-dimensional multivariate normal priors 
(Gelfand, Hills, Racine-Poon and Smith, 1990). Parameters under (e) are modeled via 12-
dimensional multivariate normal conditional autoregressive priors (Besag, York and Mollie, 
1991). The subscript “p” is used to indicate prevalence. Thus the regression model is
(2.2)
To assess this extended model, we consider a basic model (Rao, 2003) as a benchmark. The 
basic model includes fixed effects for class and a spatially unstructured random effect for 
county. The basic regression model is
(2.3)
All prior distributions appear in Appendix 2.
2.5 Conditional Incidence Model
The conditional incidence model is similar to the prevalence model:
(2.4)
where qij = the probability of incident diabetes among people with diabetes in county i, class 
j. Let s(i) denote the state s that contains county i. The regression model includes:
a. logit link function log(qij/(1 − qij)).
b. fixed effect intercept for each class (age by sex by race/ethnicity group) 
.
c. random effects by county and class .
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d. random effects by state and class .
e. spatial effects by state and class .
The subscript “c” is used to indicate “conditional incidence”, and to clearly distinguish these 
parameters from the ones in the prevalence model. As before, parameters under (c) and (d) 
are modeled via 12-dimensional multivariate normal priors. Parameters under (e) are 
modeled via 12-dimensional multivariate normal conditional autoregressive priors. Thus the 
regression model is:
(2.5)
We again consider a basic model as a benchmark. The basic model includes fixed effects for 
class and a random effect for county. The basic regression model is
(2.6)
All prior distributions appear in Appendix 2.
2.6 Estimates of Diabetes Incidence
Let Nij = the estimated number of people in county i, class j = 1, ⋯, 12, in 2009 from U.S. 
Census Bureau. Let  and  be draws from the posterior distributions of pij and qij, 
respectively. Our estimate of the number of incident diabetes cases in county i is the mean of 
the posterior predictive distribution of:
(2.7)
The estimate of the annual incidence rate in county i is the mean of the posterior predictive 
distribution of:
(2.8)
Note that the denominator in the above expression is an estimate of the number of 
nondiabetic persons in county i at the start of 2009. The estimate of the age specific number 
of incident diabetes cases in county i, age group k is the mean of the posterior predictive 
distribution of:
(2.9)
where Ak is the set of classes for age group k. The estimate of the age specific annual 
incidence rate in county i, age group k is the mean of the posterior predictive distribution of:
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Then the age-adjusted annual incidence rate for county i is the mean of the posterior 
predictive distribution of:
(2.11)
where wk is the proportion of the U.S. population in age group k as measured by the 2000 
U.S. Census.
All posterior distributions were simulated in WinBUGS (Lunn et al., 2000). The 2.5th and 
97.5th percentiles of the posterior distributions provide the 95% posterior intervals for 
county incidence of diagnosed diabetes. We treat the posterior intervals as confidence 
intervals. We run two chains, each with a burn-in of 1000 iterations followed by an 
additional 12,000 iterations. We check convergence by visual inspection of history and 
autocorrelation plots and using the Gelman-Rubin statistic, as modified by Brooks and 
Gelman (1998).
2.7 Model Comparisons
We evaluate the frequentist properties of the Bayesian estimates that we calculate using the 
model selection criterion developed in Gelfand and Ghosh (1998). This criterion depends on 
a statistic D, which combines goodness-of-fit and variability. Calculating D requires 
replicating the entire data set for each posterior draw of the model parameters. Using these 
replicates, we compute the posterior predictive mean and variance for each observation. We 
calculate G, a goodness of fit measure, as the sum over all observations of the squared 
difference between the data and its posterior predictive mean. We calculate P, a measure of 
expected mean square measure, as the sum over all observations of the posterior predictive 
variances. The statistic D is defined as G+P. Models with smaller D values, meaning that 
modeled values are more similar to observations, are preferred.
2.8 Model Checking
We implemented posterior predictive checks to examine the consistency of the model with 
the data (Gelman et al., 2004, Chapter 6.3). In posterior predictive checking, the entire data 
set is replicated for each posterior draw of the parameters. A discrepancy or test measure 
that reflects relevant aspects of the model is calculated for each replicate. We used the 
deviance (McCullagh and Nelder, 1989, Chapter 2.3) as the discrepancy measure. A 
Bayesian p-value associated with the test measure is calculated; Bayesian p-values differ 
from the more familiar frequentist p-values in that a value between 0.1 and 0.9 indicates 
reasonable model fit.
We check our model by comparing it to direct estimates. The BRFSS provides direct, 
design-based, complete-case estimates of diabetes incidence for 48 states and DC for 2009 
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(Centers for Disease Control and Prevention, 2012a). These estimates are based on the 
combined 2008, 2009, 2010 BRFSS data. We aggregate our modeled county estimates to the 
state level and plot them against the direct estimates, allowing a comparison of modeled and 
direct estimates.
In an additional model check, we set up a simulation study to evaluate the two-part, 
prevalence and conditional incidence, modeling approach. Fifteen years of BRFSS data 
(1996–2010) were combined to create the test population. This test population includes 
3,183,766 people, 285,851 with diabetes and 29,048 with incident diabetes. This population 
is too small to evaluate our model at the county level so we use the fifty states and DC as 
our “small areas”. The evaluation proceeds as:
1. Sample 20,000 individuals from our population. This approximates the average 
number of observation per county in three years of BRFSS times 51.
2. Fit the prevalence and conditional incidence models to obtain incidence estimates 
by the 51 small areas. These models exclude the μij terms.
3. Calculate direct design-based incidence estimates for the 51 small areas.
4. Repeat steps 1, 2 and 3 a total of fifty times.
5. Compare the modeled estimates to the true values from the test population.
6. Compare the direct design-based estimates to the true values from the test 
population.
Comparisons statistics in step 5 include the difference between the modeled and true values 
and the root mean squared error divided by the true incidence. Values of the root mean 
squared error divided by true value less than 0.25 are considered evidence of useful 
estimates. We generate box plots to visually present the dispersion in the difference between 
the modeled and true values. In step 6, we calculate the root mean squared error of the 
design-based estimates divided by the true incidence.
3. Results
3.1 Description of Data
Table 1 provides details (BRFSS data unweighted in this table, since we describe the sample 
and, at this stage, do not yet make inference to the population) on the number counties and 
the number of adults 20 years of age or older enumerated in the 2009 Census and surveyed 
in the 2008–2010 BRFSS. The number of respondents who self-reported diabetes and whose 
incident status is known also appears. Twelve percent of the BRFSS sample participants 
reported diagnosed diabetes. Of those, 73% have known incidence status.
3.2 Estimates
There was relatively little variation in county-level conditional incidence (proportion of 
prevalent cases which are also incident cases); estimated county-level conditional incidence 
ranged from 0.07 to 0.12, with a median value of 0.10. We looked for spatial patterns in 
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conditional incidence, such as geographic clustering or a tendency to correlate with some 
demographic, but found no evidence of such patterns (data not shown).
Estimates for incidence for all counties appear in Figure 1. Incidence estimates of diabetes 
were 0.38%–2.1% (mean 1.1%). The average coefficient of variation was 18% (range, 8%–
26%). We also calculate age-adjusted estimates (standardized to the 2000 U.S. population). 
These differed little from non-age-adjusted ones, and are not reported.
3.3 Model Comparisons
Table 2 displays G, P, and D, the model selection criteria. For both prevalence and 
conditional incidence, the basic model provides a much poorer fit than its competitors. For 
both prevalence and conditional incidence, the extended model without the spatial effects 
provides a slightly better fit than the model including the spatial effects. Spatial effects 
require substantially longer simulation runs for little or no gain. Therefore, we did not 
include spatial effects in our final estimates.
The lack of spatial effects in the final model could be viewed as counter-intuitive, since the 
prevalence of diabetes in the United States (Barker et al., 2011) exhibits strong spatial 
correlation. However, age, race/ethnicity, and state of residence, factors explicitly 
considered in our model, are also spatially correlated. These factors also serve as surrogates 
for factors that directly contribute to the incidence of type 2 diabetes (90–95% of diabetes in 
the United States [Centers for Disease Control, 2011]), such as obesity, physical inactivity, 
and lower income/educational achievement. Thus, it is likely that the spatial autocorrelation 
that remained, after accounting for age, race/ethnicity, and state of residence, was small.
3.4 Model Checking
All models considered had Bayesian p-values between 0.1 and 0.9 (minimum 0.36, 
maximum 0.81), indicating reasonably good model fit. Figure 2 is a scatterplot of incidence 
rate per 1000 person-years for direct, design-based estimates (available for 48 states and 
DC) versus modeled (aggregated up to the state level) estimates. There is good agreement 
between the estimates with the modeled estimates being slightly higher, on average, than the 
direct estimates.
The simulation study showed the modeled estimates to be quite good. Figure 3 displays the 
root mean squared error over the true value. For all but six of the estimates, the value is less 
than 0.25. All but four are less than 0.30, and, for most, the ratio is close to 0.15.
Figure 4 displays boxplots of differences (population minus modeled estimate). Only four 
states, out of 51 (counting the District of Colombia), have differences that are statistically 
significantly different from zero at the 0.05 level. The direct, design-based estimates from 
the simulation study are not usable because of large relative error. For the design-based 
estimates, the root mean squared errors divided by true values were over 0.30 for all 51 
areas, and the median value was 0.54.
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We found a concentration of high-incidence counties in the U.S. southeast and in 
Appalachia, with a scattering of high-incidence counties in the U.S. west, primarily in 
counties with large American Indian populations. The map, Figure 1, also shows a 
concentration of low-incidence counties in the state of Colorado. The pattern of county-level 
diabetes incidence in the U.S. is roughly similar to the pattern of county-level prevalence, in 
the sense that high-prevalence counties tend to be high-incidence counties as well. Both 
high-incidence and prevalence, and low-incidence and prevalence counties correlate well 
with the county-level prevalence of obesity (CDC, 2012), a strong risk factor for type 2 
diabetes. The prevalence of obesity is high in the southeast and in Appalachia, and low in 
Colorado (CDC, 2012). The scattered counties in the west with high diabetes incidence have 
high prevalence of poverty, another risk factor for type 2 diabetes, and have relatively large 
populations of American Indians, who are at greater risk of type 2 diabetes than non-
Hispanic whites, the majority of the U.S. population.
The strong association of prevalence and incidence estimates suggests that mortality among 
those with diagnosed diabetes and the rate of relocation to another county after developing 
diabetes, both of which could cause incidence and prevalence to look very different, are 
likely be relatively constant across the U.S. This was not known prior to this analysis.
Modeled estimates tended to be slightly larger than direct estimates, as depicted in Figure 2. 
This is probably due to direct estimates not accounting for those whose incidence status is 
unknown. Thus, the two estimates have somewhat different denominators, and therefore 
might be expected to differ.
Among the values of root mean squared error over the true value, Figure 3, there were four 
possible outliers: Alaska, District of Colombia, Hawaii, and Minnesota. Alaska, District of 
Colombia, and Hawaii are geographic/demographic outliers in the U.S. We have no 
explanation for Minnesota’s being on this list.
Our study is subject to several limitations. First, instead of “incidence of diabetes”, we are 
actually estimating “incidence of diagnosed diabetes”. An estimated 27% of all U.S. 
diabetes cases are undiagnosed (Centers for Disease Control, 2011). People can have type 2 
diabetes, which comprises 90–95% all diabetes (Centers for Disease Control, 2011), for 
years and be unaware of their condition. No national data set allows us to distinguish 
“incidence of diabetes” from “incidence of diagnosed diabetes”. Second, our study is subject 
to the limitations of the BRFSS, such as not adequately representing households that have no 
land-line telephone (Centers for Disease Control, 2012b). Another limitation of BRFSS is 
recall bias: people might have simply misremembered the date at which their diabetes was 
diagnosed (although, for this study, respondents need only categorize diagnosis as: within 
the current calendar year; in the preceding calendar year; or before the preceding calendar 
year). In any survey, social desirability bias can exist, although self-report of diagnosed 
diabetes is usually correct (Okura et al.). Some of the participants in the study whose county 
of residence was imputed from telephone number might have been incorrectly categorized. 
This would tend to bias county estimates toward the overall mean. Also, BRFSS does not 
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allow us to distinguish type 2 diabetes from the much less common type 1 diabetes. In our 
analysis, uncertainty in U. S. Census projections was ignored. This uncertainty is probably 
small, but not zero; however, the U.S. Census provides what is, by far, the best available 
estimates of Nij. Finally, diabetes incidence rates are likely to vary over time. Our methods 
require at least three years of BRFSS data to produce stable estimates. Thus, we are 
estimating a running average over time of incidence rates instead of the incident rate for a 
single year.
Incidence estimates stratified by demographics, such as age or race/ethnicity would have 
been desirable, since they would have provided insights into the causes of variability among 
counties in diabetes incidence. However, due to sample size limitations, such estimates have 
coefficients of variation that we consider unacceptably large. Therefore, we do not report 
such estimates.
While identifying counties of high and low diabetes incidence is of utility in directing public 
health interventions in the U.S., our methods have a broader applicability. Neither the 
methods developed in Cadwell et al. (2010) nor the modified version introduced here can be 
used to estimate rates of sufficiently rare events, such as diabetes incidence in a single state. 
However, if the outcome of interest is rare, but all cases of that outcome must also be cases 
of a more common outcome, our methods might be useful. The fraction of the population 
with the more common outcome can be estimated. Then the proportion of persons with the 
rare outcome who also have the more common outcome can be estimated. These estimates 
can be combined to estimate the faction of the population with the rare outcome. This opens 
up the possibility of data from BRFSS, or similar surveys in other countries, being used to 
provide small-area estimates of events that are too rare to be estimated in a one-stage model.
Appendix 1. Factoring the Full Probability Model
Let Z1 = 1 if an individual was diagnosed with diabetes within the past year; Z1 = 0 
otherwise. Let Z2 = 1 if an individual was diagnosed with diabetes; Z2 = 0 otherwise. Let θ = 
(θ1, θ2) be the parameters associated with conditional incidence and prevalence, 
respectively. Assuming θ1 is distinct from θ2 and their prior distributions are independent 
then
(A.1)
Therefore the posterior distribution factors into two independent posterior distributions. 
Each part of the posterior can then be evaluated separately.
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Appendix 2. Prior Assumptions
The intercepts by class are assigned improper flat priors, α ≺ 1.
The spatially correlated effects by county and class, ω, are assigned a multivariate normal 
(MVN) conditional autoregressive prior (Besag, York and Mollie, 1991). Let ωi = (ωi1, ωi2, 
⋯, ωi12)′. Then
(A.2)
where ω(−i) equals the matrix ω′ with the ith column removed,  and δi and ni 
denote the set of labels of the neighbors of county i and the number of neighbors, 
respectively, where counties are consider to be “neighbors” if they have a common border. 
The inverse of Σω is assigned a Wishart prior with scale matrix Sω and 12 degrees of 
freedom. The matrix Sω has ones along the main diagonal and 0.001 for all other elements 
(Rao, 2003).
The spatially unstructured effects by county and class, μ, are assigned a multivariate (of 
dimension 14) normal prior with mean zero and variance matrix Σμ. The inverse of Σμ is 
assigned a Wishart prior with scale matrix Sμ and 14 degrees of freedom. The matrix Sμ has 
ones along the main diagonal and 0.001 for all other elements (Rao, 2003). The spatially 
unstructured effects by state and class, ν, are assigned the same types of priors as μ.
The error terms, ε, in the basic models are assigned a proper half-Cauchy (Gelman and Hill, 
2007, Chapter 19) prior distribution with median equal to one. This is a diffuse prior. For 
this model, its use greatly speeds convergence.
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Map of 2009 diabetes incidence for 3143 U.S. counties
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Scatterplot of design-based state incidence versus model-based county incidence aggregated 
to the state level for 48 states and the District of Columbia
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Scatterplot of root mean squared error of model-based incidence estimates over population 
value versus area. Results are averaged over 50 random samples from the test population
Barker et al. Page 16














Box plots of difference in incidence, population minus model-based, by area. Each plot box 
represents 50 random samples from the test population
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Table 1
Descriptive statistics of the Census and BRFSS data
BRFSS 2008–2010
Census 2009 Diabetes Prevalence Conditional Incidence
Counties 3143 3140 2981
Responses – 152,391 9676
median (min, max)
per county
– 18 (0, 13000) 1 (0, 88)
Observations 223,585,859 1,255,029 110,765
median (min, max)
per county
18885 (36, 7057285) 142 (2, 11967)* 14 (1, 1127)*
*
Among counties with greater than zero observations.
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Table 2
Model selection criterion
Outcome Model Goodness of Fit G Predictive Error P D*
Prevalence Basic 153,335 143,990 297,225
Extended 65,368 175,465 240,833
Extended, without spatial 66,310 174,444 240,755
Conditional Incidence Basic 7084 8765 15,849
Extended 5594 9783 15,377
Extended, without spatial 5635 9727 15,362
*
Smaller is better.
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